Oyster & Pearl Hospitals
Welcome,         Profile    Billing    Logout  
 1 Trial 
2 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Goyal, Ashish O
PRISM, NCT04276233: Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma

Completed
4
100
RoW
Mepolizumab, Salbutamol
GlaxoSmithKline, Tech Observer
Asthma
10/23
10/23
NCT04533022 / 2020-000822-24: Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

Hourglass May 2023 - May 2023 : Safety and efficacy of AIR study in idiopathic pulmonary fibrosis
Checkmark Interim data from AIR STUDY for IPF
Nov 2022 - Nov 2022: Interim data from AIR STUDY for IPF
Checkmark Interim data from AIR STUDY for IPF
Feb 2022 - Feb 2022: Interim data from AIR STUDY for IPF
Completed
2
52
Europe, RoW
C21
Vicore Pharma AB, Orphan Reach
Idiopathic Pulmonary Fibrosis
03/24
03/24

Download Options